Hypofibrinolytic State in Subjects with Type 2 Diabetes Mellitus Aggravated by the Metabolic Syndrome before Clinical Manifestations of Atherothrombotic Disease

Background. Metabolic and genetic factors induce plasminogen activator inhibitor type-1 (PAI-1) overexpression; higher PAI-1 levels decrease fibrinolysis and promote atherothrombosis. Aim. To assess PAI-1 antigen levels among subjects with type 2 diabetes mellitus (T2DM) plus Metabolic Syndrome (Met...

Descripción completa

Detalles Bibliográficos
Autores principales: Aburto-Mejía, Elsa, Santiago-Germán, David, Martínez-Marino, Manuel, María Eugenia Galván-Plata, Almeida-Gutiérrez, Eduardo, López-Alarcón, Mardia, Hernández-Juárez, Jesús, Alvarado-Moreno, Antonio, Leaños-Miranda, Alfredo, Majluf-Cruz, Abraham, Isordia-Salas, Irma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5320378/
https://www.ncbi.nlm.nih.gov/pubmed/28271069
http://dx.doi.org/10.1155/2017/6519704

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5320378/
https://www.ncbi.nlm.nih.gov/pubmed/28271069
http://dx.doi.org/10.1155/2017/6519704

Ejemplares similares